Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases. Based in Milan, Italy, Genespire was founded in March 2020 by the gene therapy pioneer Prof. Luigi Naldini, Dr. Alessio Cantore, Fondazione Telethon and Ospedale San Raffaele. It is a spin-off of SR-Tiget, a world leading cell and gene therapy research institute and is backed by Sofinnova Partners.
| Website | http://www.genespire.com |
| Employees | 17 (8 on RocketReach) |
| Founded | 2020 |
| Address | Via Vincenzo Gioberti, 8, Milan, Lombardy 20123, IT |
| Technologies |
JavaScript
,
HTML
,
PHP
+9 more
(view full list)
|
| Industry | Biotechnology Research, Drug Discovery, Biotechnology |
| Keywords | Precision Medicine, Gene Therapy, Transformative Therapies, Genetic Diseases, Biotechnology, Drug Development, Rare Diseases, Clinical Trials, Gene Editing, Genome Engineering, Personalized Medicine, Regenerative Medicine, Pharmaceutical Research, Genetic Engineering, Biopharma, Molecular Biology, Cell Therapy, Immunology Research |
| Competitors | Amgen, Thermo Fisher Scientific, Novartis, Vertex Pharmaceuticals, Illumina, Regeneron, bluebird bio, Intellia Therapeutics, Inc., Editas Medicine, ZYAGEN +33 more (view full list) |
Looking for a particular Genespire employee's phone or email?
Julianne Smith is the Chief Development Officer of Genespire.
8 people are employed at Genespire.
Genespire is based in Milan, Lombardy.